Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands

MLA

Ali N. Kamali, et al. “Immune Checkpoints and Cancer Immunotherapies: Insights into Newly Potential Receptors and Ligands.” Therapeutic Advances in Vaccines and Immunotherapy, vol. 11, Aug. 2023. EBSCOhost, https://doi.org/10.1177/25151355231192043.

APA

Ali N. Kamali, José M. Bautista, Michael Eisenhut, & Haleh Hamedifar. (2023). Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands. Therapeutic Advances in Vaccines and Immunotherapy, 11. https://doi.org/10.1177/25151355231192043

Chicago

Ali N. Kamali, José M. Bautista, Michael Eisenhut, and Haleh Hamedifar. 2023. “Immune Checkpoints and Cancer Immunotherapies: Insights into Newly Potential Receptors and Ligands.” Therapeutic Advances in Vaccines and Immunotherapy 11 (August). doi:10.1177/25151355231192043.